Early growth response 3 (Egr3) is highly over-expressed in non-relapsing prostate cancer but not in relapsing prostate cancer.

PLoS One · 2013 · PMC3544741 · PMID 23342084

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Mean expression in prostate cancer is 5.35 fold higher than in normal prostate tissue and a student’s t-test ( p = 2×10 −15 ) confirmed that this difference is highly significant.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.